Pharmaceutical Health Sciences cover a wide range of research on the evaluation, diagnosis, prevention, and treatment of disorders, diseases and conditions of the body functions and their impact on the human body. The discipline of research on Pharmacy has undergoing changes in range, methods, instrumentation and technology which is propelled by increased awareness of quality care in pharmacist researches in the field of Pharmaceutical Health Sciences. The field of pharmacy is evolving at a rapid pace, with the introduction of several materials, instruments, and equipment’s. However, there is minimum information of their relevance of Pharmacy. Pharmaceuticals in one of the main and essential field for the welfare of human society and it is also one of the largest in the global economy. The total value of the pharmaceutical sector is over $5 trillion. It is one thousand-fold more when compared to what is was in the 1920s. Moreover, the pharmaceutical industry is likely to triple in size in by 2060 and the pharmaceutical industry

Scope and Importance:

One in four individual in the globe will be affected by drug side effects at some point in their lives. Often, when a patient loses consciousness due to disease. Pharmacy is more vital to the common public than ever before, and with the rise of reported drug effect, it might seem a bit confusing as to why personalities still tend to ignore the consequences of leaving these symptoms crude, USD 8.67 billion in 2016 and is projected to reach USD 15.90 billion by 2025, growing at a CAGR of 6.97% from 2017 to 2025. A unique model is customized for each study. Gathered information for technology landscape, market dynamics, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market projecting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. The global market for individual drugs was given as per the below, and as per the chart it describes the respective drug’s market values in present economic year i.e., 2017 or 2018 in billion USD and expected growth rate by 2022 and 2023 and the CAGR is given in percentage growth.

3M Company Alkermes Antares Pharma, Inc. Bayer AG Becton, Dickinson And Company F. Hoffmann-La Roche Ltd. Generex Biotechnology Glaxosmithkline Plc Johnson & Johnson Services, Inc. Merck & Co., Inc. Novartis AG Pfizer, Inc. Psivida Corporation Sanofi S.A. Vectura Group Plc.

Target Audience:

• Drug Delivery Technology Manufacturers

• Public and Private Physicians

• Healthcare Institutions (Medical Data Centers)

• Research & Clinical Laboratories

• Distributors and Suppliers of Drug Delivery Technologies

• Health Insurance Payers

• Market Research and Consulting Firms

• Drug Delivery Technology Market, by Region

• North America: U.S & Canada

• Europe: Germany, France, U.K, Rest of Europe (RoE)

• Asia: China, India, Japan, Rest of Asia (RoA), Rest of the World (RoW)

Pharma companies have always interacted with consumers. They have marketed directly to users, especially in the U.S., and they involve patients in clinical trials. They thus have some limited experience with consumer-facing business models. In this new era, pharma companies will have to become more proactive with large communities of patients and go beyond lip service in meeting the needs of a wide swath of consumers.

The United States is leading with $339,694 million per capita through its pharmaceuticals market, followed by Japan in second place with $94,025 million and China in third place with $86,774 million.

The global market for individual drugs was given as per the below, and as per the chart it describes the respective drug’s market values in present economic year i.e., 2017 or 2018 in billion USD and expected growth rate by 2022 and 2023 and the CAGR is given in percentage growth.

Pharmaceutical excipients have its value of 6.8 billion USD in 2017 and it is expected to reach 8.7 billion USD by 2022 and its CAGR will be 4.9% from 2017-2022.

Lung Cancer therapeutics has its value of 17.9billion USD in 2018 and it is expected to reach 26.3 billion USD by 2023 and its CAGR will be 8.0% from 2018-2023.

Bioinformatics has its value of 6.4 billion USD in 2017 and it is expected to reach 16 billion USD by 2022 and its CAGR will be 20.0% from 2017-2022.

HIV therapeutics has its value of 22 billion USD in 2017 and it is expected to reach 27.1 billion USD by 2022 and its CAGR will be 8.0% from 2017-2022.

Lysosomal storage diseases have its value of 5.1 billion USD in 2018 and it is expected to reach 7.6 billion USD by 2023 and its CAGR will be 8.3% from 2018-2023.

Proteomics has its value of 7.9 billion USD in 2017 and it is expected to reach 16.8 billion USD by 2022 and its CAGR will be 16.2% from 2017-2022.

Antipsychotic drugs have its value of 13.2 billion USD in 2018 and it is expected to reach 14.5 billion USD by 2023 and its CAGR will be 1.9% from 2018-2023.

Protein analysis methods have its value of 11.6 billion USD in 2018 and it is expected to reach 19 billion USD by 2023 and its CAGR will be 10.4% from 2018-2023.

Cell-based assays technical and methods have its value of 20.1 billion USD in 2018 and it is expected to reach 32.7 billion USD by 2023 and its CAGR will be 10.2% from 2018- 2023.

Zareen Delawar Husssain will be taking privilege of felicitating organizing committee member. With the support of organizing committee, ME Conferences is organizing the upcoming event .We are honoured to schedule our next series “21^st Middle East Pharma Tech and Expo” during November 23-24, 2020 at Istanbul, Turkey which will be revolving around the theme “Innovations, Outcomes and New Technologies in Pharmaceutical Sciences and Drug Discovery Systems”.

Henry Benjamin

Program Manager | Pharma Middle East 2020

Send a mail to pharma@memeetings.com

Phone No.: +12013805561

WhatsApp No.:+447452259145

• 21st Pharma Middle East Congress

  November 23-24, 2020

  Istanbul, Turkey